{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:05:39Z","timestamp":1783926339920,"version":"3.55.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejmech.2026.119044","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:28:09Z","timestamp":1780759689000},"page":"119044","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Synthetic heterocyclic scaffolds relevant to human 15-lipoxygenase-2 (h15-LOX-2) inhibition: Scaffold diversity, structure-activity relationships, selectivity challenges, and future directions"],"prefix":"10.1016","volume":"316","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7802-7359","authenticated-orcid":false,"given":"Syahrul","family":"Imran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119044_bib1","first-page":"28","article-title":"Emerging role of 12\/15-Lipoxygenase (ALOX15) in human pathologies","volume":"vol. 73","author":"Singh","year":"2019"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119044_bib2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1021\/acs.jmedchem.4c01884","article-title":"Identification of novel human 15-Lipoxygenase-2 (h15-LOX-2) inhibitors using a virtual screening approach","volume":"68","author":"Viviani","year":"2025","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119044_bib3","article-title":"15-Lipoxygenase-2 deficiency induces foam cell formation that can be restored by salidroside through the inhibition of arachidonic acid effects","volume":"20","author":"Huang","year":"2025","journal-title":"Open Life Sci."},{"key":"10.1016\/j.ejmech.2026.119044_bib4","article-title":"Regulation and functions of 15-Lipoxygenases in human macrophages","volume":"vol. 10","author":"Snodgrass","year":"2019"},{"issue":"12","key":"10.1016\/j.ejmech.2026.119044_bib5","doi-asserted-by":"crossref","first-page":"8562","DOI":"10.1074\/jbc.M113.543777","article-title":"The structure of human 15-lipoxygenase-2 with a substrate mimic","volume":"289","author":"Kobe","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119044_bib6","article-title":"Arachidonate 15-lipoxygenase type B: regulation, function, and its role in pathophysiology","volume":"vol. 13","author":"Benatzy","year":"2022"},{"key":"10.1016\/j.ejmech.2026.119044_bib7","article-title":"Dual COX-2\/15-LOX inhibitors: a new avenue in the prevention of cancer","volume":"vol. 261","author":"Aliabadi","year":"2023"},{"key":"10.1016\/j.ejmech.2026.119044_bib8","article-title":"Structural and functional biology of mammalian ALOX isoforms with particular emphasis on enzyme dimerization and their allosteric properties","volume":"vol. 25","author":"Zhuravlev","year":"2024"},{"issue":"11","key":"10.1016\/j.ejmech.2026.119044_bib9","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.2174\/0929867327999200820173853","article-title":"The emerging role of COX-2, 15-LOX and PPAR\u03b3 in metabolic diseases and cancer: an introduction to novel multi-target directed ligands (MTDLs)","volume":"28","author":"Alaaeddine","year":"2020","journal-title":"Curr. Med. Chem."},{"issue":"25","key":"10.1016\/j.ejmech.2026.119044_bib10","article-title":"Discovering selective antiferroptotic inhibitors of the 15LOX\/PEBP1 complex noninterfering with biosynthesis of lipid mediators","volume":"120","author":"Dar","year":"2023","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.ejmech.2026.119044_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116349","article-title":"Kinetic and structural investigations of novel inhibitors of human epithelial 15-lipoxygenase-2","volume":"46","author":"Tsai","year":"2021","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119044_bib12","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1021\/acs.jctc.5b01236","article-title":"Understanding the mechanism of the hydrogen abstraction from arachidonic acid catalyzed by the human enzyme 15-Lipoxygenase-2. A quantum mechanics\/molecular mechanics free energy simulation","volume":"12","author":"Suard\u00edaz","year":"2016","journal-title":"J. Chem. Theor. Comput."},{"issue":"20","key":"10.1016\/j.ejmech.2026.119044_bib13","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1021\/acs.biochem.5b01339","article-title":"Strict regiospecificity of human epithelial 15-Lipoxygenase-2 delineates its transcellular synthesis potential","volume":"55","author":"Green","year":"2016","journal-title":"Biochemistry"},{"issue":"23","key":"10.1016\/j.ejmech.2026.119044_bib14","doi-asserted-by":"crossref","first-page":"19721","DOI":"10.1021\/acsomega.2c01439","article-title":"4-Chlorophenyl- N-furfuryl-1,2,4-triazole methylacetamides as significant 15-Lipoxygenase inhibitors: an efficient approach for finding lead anti-inflammatory compounds","volume":"7","author":"Yasin","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2026.119044_bib15","first-page":"65","article-title":"15-Lipoxygenase inhibitors: a patent review","volume":"vol. 26","author":"Sadeghian","year":"2016"},{"key":"10.1016\/j.ejmech.2026.119044_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103657","article-title":"Further insight into the dual COX-2 and 15-LOX anti-inflammatory activity of 1,3,4-thiadiazole-thiazolidinone hybrids: the contribution of the substituents at 5th positions is size dependent","volume":"97","author":"Omar","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119044_bib17","first-page":"3745","article-title":"5-Lipoxygenase as a drug target: a review on trends in inhibitors structural design, SAR and mechanism based approach","volume":"vol. 27","author":"Sinha","year":"2019"},{"issue":"8","key":"10.1016\/j.ejmech.2026.119044_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104094","article-title":"A high throughput screen identifies potent and selective inhibitors to human epithelial 15-lipoxygenase-2","volume":"9","author":"Jameson","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.119044_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.139963","article-title":"Exploration of 4-tolyl-5-(p-tolyloxymethyl)-4H-1,2,4-triazole thioethers as potent 15-LOX inhibitors supported by in vitro, in silico, MD simulation and DNA binding studies","volume":"1321","author":"Iqbal","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2026.119044_bib20","first-page":"297","article-title":"The role of lipoxygenases in pathophysiology; new insights and future perspectives","volume":"vol. 6","author":"Mashima","year":"2015"},{"issue":"3","key":"10.1016\/j.ejmech.2026.119044_bib21","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1167\/iovs.04-1166","article-title":"Detection and subcellular localization of two 15S-lipoxygenases in human cornea","volume":"46","author":"Chang","year":"2005","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"19","key":"10.1016\/j.ejmech.2026.119044_bib22","doi-asserted-by":"crossref","first-page":"7850","DOI":"10.1021\/acs.jmedchem.5b01121","article-title":"Rational development of a potent 15-Lipoxygenase-1 inhibitor with in vitro and ex vivo anti-inflammatory properties","volume":"58","author":"Eleftheriadis","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119044_bib23","first-page":"308","article-title":"Mammalian lipoxygenases and their biological relevance","volume":"vol. 1851","author":"Kuhn","year":"2015"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119044_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2362.2009.02223.x","article-title":"15-Lipoxygenase-2 is expressed in macrophages in human carotid plaques and regulated by hypoxia-inducible factor-1\u03b1","volume":"40","author":"Hult\u00e9n","year":"2010","journal-title":"Eur. J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119044_bib25","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1161\/01.ATV.0000144951.08072.0b","article-title":"Hypoxia increases LDL oxidation and expression of 15-Lipoxygenase-2 in human macrophages","volume":"24","author":"Rydberg","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119044_bib26","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.atherosclerosis.2011.01.015","article-title":"12- and 15-lipoxygenases in human carotid atherosclerotic lesions: associations with cerebrovascular symptoms","volume":"215","author":"Gertow","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejmech.2026.119044_bib27","first-page":"371","article-title":"The double-edged role of 12\/15-lipoxygenase during inflammation and immunity","volume":"vol. 1862","author":"Ackermann","year":"2017"},{"key":"10.1016\/j.ejmech.2026.119044_bib28","article-title":"Emerging cellular functions of the lipid metabolizing enzyme 15-Lipoxygenase-1","volume":"vol. 51","author":"\u00c7olako\u011flu","year":"2018"},{"key":"10.1016\/j.ejmech.2026.119044_bib29","first-page":"1048","article-title":"Lipoxin and aspirin-triggered lipoxins","volume":"vol. 10","author":"Romano","year":"2010"},{"issue":"35","key":"10.1016\/j.ejmech.2026.119044_bib30","doi-asserted-by":"crossref","first-page":"12746","DOI":"10.1073\/pnas.1404372111","article-title":"Phospholipase A2 regulates eicosanoid class switching during inflammasome activation","volume":"111","author":"Norris","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1016\/j.ejmech.2026.119044_bib31","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1194\/jlr.M033746","article-title":"Biosynthesis, isolation, and NMR analysis of leukotriene A epoxides: substrate chirality as a determinant of the cis or trans epoxide confi guration","volume":"54","author":"Jin","year":"2013","journal-title":"JLR (J. Lipid Res.)"},{"key":"10.1016\/j.ejmech.2026.119044_bib32","first-page":"16","article-title":"15-Lipoxygenases in cancer: a double-edged sword?","volume":"106","author":"Klil-Drori","year":"2013"},{"issue":"12","key":"10.1016\/j.ejmech.2026.119044_bib33","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nsb1297-1003","article-title":"The structure of mammalian 15-lipoxygenase reveals similarity to the lipases and the determinants of substrate specificity","volume":"4","author":"Gillmor","year":"1997","journal-title":"Nat. Struct. Biol."},{"issue":"53","key":"10.1016\/j.ejmech.2026.119044_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/chem.202402279","article-title":"Investigating the catalytic site of human 15-Lipoxygenase-1 via marine natural products","volume":"30","author":"Spacho","year":"2024","journal-title":"Chem. Eur J."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119044_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202418291","article-title":"Crafting molecular tools for 15-Lipoxygenase-1 in a single step","volume":"64","author":"Louka","year":"2025","journal-title":"Angewandte Chemie - International Edition"},{"key":"10.1016\/j.ejmech.2026.119044_bib36","article-title":"Thirty years with three-dimensional structures of lipoxygenases","volume":"vol. 752","author":"Oliw","year":"2024"},{"issue":"8","key":"10.1016\/j.ejmech.2026.119044_bib37","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1021\/acs.jpcb.5b09897","article-title":"How can linoleic acid be the preferential substrate of the enzyme 15-Lipoxygenase-1? A QM\/MM approach","volume":"120","author":"Soler","year":"2016","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejmech.2026.119044_bib38","first-page":"298","article-title":"The structural basis for specificity in lipoxygenase catalysis","volume":"vol. 24","author":"Newcomer","year":"2015"},{"issue":"3","key":"10.1016\/j.ejmech.2026.119044_bib39","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/prot.21590","article-title":"Conformational flexibility in mammalian 15S-lipoxygenase: reinterpretation of the crystallographic data","volume":"70","author":"Choi","year":"2008","journal-title":"Proteins: Structure, Function and Genetics"},{"key":"10.1016\/j.ejmech.2026.119044_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105261","article-title":"Exploring phenylcarbamoylazinane-1,2,4-triazole thioethers as lipoxygenase inhibitors supported with in vitro, in silico and cytotoxic studies","volume":"115","author":"Shahid","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119044_bib41","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.bioorg.2018.06.036","article-title":"Synthesis, biological evaluation and docking study of 1,3,4-thiadiazole-thiazolidinone hybrids as anti-inflammatory agents with dual inhibition of COX-2 and 15-LOX","volume":"80","author":"Omar","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119044_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115403","article-title":"Novel class of benzimidazole-thiazole hybrids: the privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes","volume":"28","author":"Maghraby","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119044_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115724","article-title":"Magic shotgun approach to anti-inflammatory pharmacotherapy: synthesis of novel thienopyrimidine monomers\/heterodimer as dual COX-2 and 15-LOX inhibitors endowed with potent antioxidant activity","volume":"260","author":"Elsayed","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119044_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107244","article-title":"Tailored quinoline hybrids as promising COX-2\/15-LOX dual inhibitors endowed with diverse safety profile: design, synthesis, SAR, and histopathological study","volume":"145","author":"Hegazy","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119044_bib45","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejmech.2015.03.007","article-title":"Identification of 6-benzyloxysalicylates as a novel class of inhibitors of 15-lipoxygenase-1","volume":"94","author":"Eleftheriadis","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119044_bib46","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ejmech.2018.01.026","article-title":"Design, synthesis, biological evaluation and docking studies of new 3-(4,5-dihydro-1H-pyrazol\/isoxazol-5-yl)-2-phenyl-1H-indole derivatives as potent antioxidants and 15-lipoxygenase inhibitors","volume":"145","author":"ElBordiny","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119044_bib47","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1080\/14756366.2020.1742116","article-title":"Design, synthesis, molecular modelling and biological evaluation of novel 3-(2-naphthyl)-1-phenyl-1H-pyrazole derivatives as potent antioxidants and 15-Lipoxygenase inhibitors","volume":"35","author":"Ali","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119044_bib48","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.bioorg.2019.03.076","article-title":"Synthesis and biological evaluation of purine-pyrazole hybrids incorporating thiazole, thiazolidinone or rhodanine moiety as 15-LOX inhibitors endowed with anticancer and antioxidant potential","volume":"87","author":"Afifi","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119044_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106984","article-title":"Molecular hybrids of substituted phenylcarbamoylpiperidine and 1,2,4-triazole methylacetamide as potent 15-LOX inhibitors: design, synthesis, DFT calculations and molecular docking studies","volume":"143","author":"Nawaz","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119044_bib50","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1515\/pac-2024-0356","article-title":"Investigating the potential of prenylated and geranylated acylphloroglucinol-based xanthenones as potent soybean 15-lipoxygenase inhibitors: a combined in vitro and in silico approach","volume":"97","author":"Segaran","year":"2025","journal-title":"Pure Appl. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119044_bib51","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1007\/s00044-017-1968-9","article-title":"Discovery two potent and new inhibitors of 15-lipoxygenase: (E)-3-((3,4-dihydroxybenzylidene) amino)-7-hydroxy-2H-chromen-2-one and (E)-O-(4-(((7-hydroxy-2-oxo-2H-chromen-3-yl) imino)methine) phenyl)dimethylcarbamothioate","volume":"26","author":"Nu\u00f1ez","year":"2017","journal-title":"Med. Chem. Res."},{"issue":"31","key":"10.1016\/j.ejmech.2026.119044_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202401772","article-title":"Isoniazid derivatives as potential Lipoxygenase-15 inhibitors: In-vitro and In-silico studies","volume":"9","author":"Alghamdi","year":"2024","journal-title":"ChemistrySelect"},{"issue":"23","key":"10.1016\/j.ejmech.2026.119044_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29235540","article-title":"QSAR modeling and biological testing of some 15-LOX inhibitors in a series of Homo- and heterocyclic compounds","volume":"29","author":"Khairullina","year":"2024","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119044_bib54","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1021\/acsomega.7b01622","article-title":"Computational analysis of LOX1 inhibition identifies descriptors responsible for binding selectivity","volume":"3","author":"Gousiadou","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2026.119044_bib55","article-title":"Synthetically-tailored and nature-derived dual COX-2\/5-LOX inhibitors: structural aspects and SAR","volume":"225","author":"Meshram","year":"2021"},{"key":"10.1016\/j.ejmech.2026.119044_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2022.109317","article-title":"Structural basis for altered positional specificity of 15-lipoxygenase-1 with 5S-HETE and 7S-HDHA and the implications for the biosynthesis of resolvin E4","volume":"727","author":"Perry","year":"2022","journal-title":"Arch. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119044_bib57","doi-asserted-by":"crossref","DOI":"10.1186\/s13104-015-1101-4","article-title":"Exploration of binding site pattern in arachidonic acid metabolizing enzymes, cyclooxygenases and lipoxygenases","volume":"8","author":"Reddy","year":"2015","journal-title":"BMC Res. Notes"},{"issue":"12","key":"10.1016\/j.ejmech.2026.119044_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241210046","article-title":"Functional characterization of mouse and human arachidonic acid lipoxygenase 15B (ALOX15B) orthologs and of their mutants exhibiting humanized and murinized reaction specificities","volume":"24","author":"Kakularam","year":"2023","journal-title":"Int. J. Mol. Sci."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426004897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426004897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:14:41Z","timestamp":1783923281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426004897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":58,"alternative-id":["S0223523426004897"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119044","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthetic heterocyclic scaffolds relevant to human 15-lipoxygenase-2 (h15-LOX-2) inhibition: Scaffold diversity, structure-activity relationships, selectivity challenges, and future directions","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119044"}}